CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Subscription Receivables	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2023	$ 4	$ 381,264	$ (60,710)	$ (473,602)	$ (153,044)
Balance at beginning (in shares) at Dec. 31, 2023	516,404
Net Income (Loss)				(118,018)	(118,018)
Termination of Forward Purchase Agreements			$ 60,710		60,710
Issuance of shares and reclassification of liability related to cashless warrant exercises		10,350			$ 10,350
Issuance of shares and reclassification of liability related to cashless warrant exercises (in shares)	13,374				13,374
Stock-based compensation expense		1,621			$ 1,621
Balance at the ending at Mar. 31, 2024	$ 4	393,235		(591,620)	(198,381)
Balance at ending (in shares) at Mar. 31, 2024	529,778
Balance at the beginning at Dec. 31, 2024	$ 4	403,024		(431,597)	$ (28,569)
Balance at beginning (in shares) at Dec. 31, 2024	555,511				555,511
Net Income (Loss)				9,095	$ 9,095
Issuance of shares and reclassification of liability related to cashless warrant exercises	$ 5	6,417			$ 6,422
Issuance of shares and reclassification of liability related to cashless warrant exercises (in shares)	9,983,104				9,427,533
Stock-based compensation expense		1,729			$ 1,729
Balance at the ending at Mar. 31, 2025	$ 9	$ 411,170		$ (422,502)	$ (11,323)
Balance at ending (in shares) at Mar. 31, 2025	10,538,615				10,538,615